{
    "Trade/Device Name(s)": [
        "VIDAS BRAHMS PCT Assay",
        "VIDAS BRAHMS PCT"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K071146",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NTM"
    ],
    "Summary Letter Date": "August 30, 2007",
    "Summary Letter Received Date": "September 4, 2007",
    "Submission Date": "March 1, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.3210"
    ],
    "Regulation Name(s)": [
        "Endotoxin Assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Procalcitonin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (lithium heparin)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VIDAS instruments"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-Linked Fluorescent Assay (ELFA)",
        "Immunoassay"
    ],
    "Methodologies": [
        "Sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for VIDAS BRAHMS PCT Assay, an automated ELFA immunoassay for procalcitonin measurement on VIDAS instruments.",
    "Indications for Use Summary": "Automated test for use on VIDAS instruments to determine human procalcitonin in serum or plasma, aiding in risk assessment of critically ill ICU patients for progression to severe sepsis and septic shock.",
    "fda_folder": "Microbiology"
}